XTLB

XTL Biopharmaceuticals-ADR Cross-source read$2.56 1.59%
Health CareCUSIP 98386D406· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 opened and 1 reduced; the largest holder to move was GAMMA Investing LLC (−64%). No open-market insider trades in the last 180 days.

Tracked 13F holders
4
13F value (tracked)
$18K
Smart-money readNeutral
Net sellingNet buying
Funds · active managers, latest 13F
1 adding · 1 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

No leg leans either way.

Price & smart-money activity

$2.56 1.59%5Y -84.4%
$1.04$5.46$9.89$14.32$18.7420212022202320242025202643
Hover for who · click for detailEnd-of-day closing prices52w $2.06 – $8.20

Who owns XTLB?

4 tracked 13F filers · ranked by shares held

4 tracked 13F filers disclose a position in XTLB as of the latest SEC 13F filings, a combined $18K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Rhumbline Advisers6K
$14K
−80%
Reduced · −24K sh
Q1 2026
2GAMMA Investing LLC1K
$3K
−64%
Reduced · −2K sh
Q2 2026
3Tower Research Capital LLC (TRC)244
$588
New
+244 sh
Q1 2026
4Morgan Stanley10
$24
−99%
Reduced · −2K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is XTLB being bought or sold by institutions?

Last quarter, 1 fund opened a new position in XTLB, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Reduced
1
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own XTLB also own

CompanyCo-held byTheir position there
Apple IncAAPL2 funds$232.9M
Nvidia CorpNVDA2 funds$202.2M
Microsoft CorpMSFT2 funds$167.9M
Invesco QQQ Trust Series 1QQQ2 funds$143.5M
Micron Technology IncMU2 funds$129.9M
Broadcom IncAVGO2 funds$112.4M
Alphabet Inc-CL AGOOGL2 funds$110.9M
Tesla IncTSLA2 funds$98.9M
Amazon.com IncAMZN2 funds$93.7M
Alphabet Inc-CL CGOOG2 funds$74.4M
JPMorgan Chase & CoJPM2 funds$66.7M
Meta Platforms Inc-Class AMETA2 funds$59.7M

Ranked by how many of XTLB's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in XTLB.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Nov 19, 2008Edelman Joseph10% OwnerSell (S)9.6M$1.4M
Nov 18, 2008Edelman Joseph10% OwnerSell (S)
7 lots, same day
30.5M$4.3M
Jun 10, 2008Cho Michael10% OwnerBuy (P)
2 lots, same day
51K$165K
Jun 9, 2008Perceptive Advisors Llc10% OwnerBuy (P)
2 lots, same day
34K$113K
Jun 6, 2008Perceptive Advisors Llc10% OwnerBuy (P)
2 lots, same day
100K$343K
Jun 5, 2008Perceptive Advisors Llc10% OwnerBuy (P)
4 lots, same day
300K$967K
Jun 4, 2008Perceptive Life Sciences Master Fund Ltd10% OwnerBuy (P)
2 lots, same day
25K$75K
Jun 3, 2008Perceptive Life Sciences Master Fund Ltd10% OwnerBuy (P)
2 lots, same day
401K$1.2M
May 2, 2008Perceptive Advisors Llc10% OwnerBuy (P)
2 lots, same day
50K$194K
May 1, 2008Perceptive Advisors Llc10% OwnerBuy (P)
2 lots, same day
105K$394K
Apr 30, 2008Perceptive Life Sciences Master Fund Ltd10% OwnerBuy (P)
2 lots, same day
128K$480K
Apr 29, 2008Perceptive Life Sciences Master Fund Ltd10% OwnerBuy (P)
2 lots, same day
229K$812K

One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
03
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
XTLB is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

15 most recent

Keep exploring

Connected entities for XTLB

Browse more

Build

Ask your agent what changed in XTLB

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/XTLB/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for XTLB.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for XTLB. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.